Evidence map›Paper›PMID 42625620›Full record

ArticleCureus2026

Histoplasmosis or Blastomycosis in a Patient With Left Ventricular Assist Device.

Kiran Gajurel

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kiran GajurelInfectious Diseases, Carolinas Medical Center, Advocate Health, Charlotte, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histoplasma and Blastomyces are environmentally acquired fungi that can cause a wide spectrum of clinical disease, ranging from asymptomatic to life-threatening illness. These fungal infections are rarely encountered in patients with a left ventricular assist device (LVAD), with only one case of histoplasmosis reported in the literature. We report histoplasmosis or blastomycosis with possible infection of the underlying LVAD. The patient is a 55-year-old male with an implantable cardioverter-defibrillator (ICD) and an LVAD for sarcoid-related cardiomyopathy. He was on infliximab for sarcoidosis and presented with a fever of unclear etiology along with fatigue, poor appetite, and weight loss. Blood and urine cultures were negative. There was no drainage of the drive line (DL) exit site. A CT of the chest and abdomen showed nonspecific pulmonary ground-glass opacities and no intra-abdominal abscess. Eventually, urine Histoplasma and serum Blastomyces antigens returned positive. The patient was started on itraconazole, and infliximab was stopped. The patient started improving, and Histoplasma and Blastomyces antigen levels started declining. Since the fungal blood culture was negative and there was no end-organ disease for biopsy or fungal culture, we could not distinguish between histoplasmosis and blastomycosis. This case underscores the rarity of histoplasmosis/blastomycosis in patients with LVADs.

Indexed as

antigenblastomyceshistoplasmaleft ventricular assist devicesarcoidosis

Identifiers

PMID42625620
PMCPMC13489809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.